P480: DNMT AND HDAC INHIBITION INDUCES IMMUNOGENIC NEOANTIGENS FROM HUMAN ENDOGENOUS RETROVIRAL ELEMENT-DERIVED TRANSCRIPTS

• Ashish Goyal,
• Jens Bauer,
• Joschka Hey,
• Dimitris Papageorgiou,
• Ekaterina Stepanova,
• Michael Daskalakis,
• Marissa Dubbelaar,
• Boris Klimovich,
• Melanie Maerklin,
• Malte Roerden,
• Oliver Muecke,
• Hans-Georg Rammensee,
• Fabricio Loayza-Puch,
• Jeroen Krijgsveld,
• Michael Lübbert,
• Juliane Walz,
• Christoph Plass

Affiliations

Ashish Goyal

1 German Cancer Research Center, Cancer Epigenomics, Heidelberg, Germany

Jens Bauer

2 University Hospital Tübingen, Peptide-based Immunotherapy, Tübingen, Germany

Joschka Hey

1 German Cancer Research Center, Cancer Epigenomics, Heidelberg, Germany

Dimitris Papageorgiou

3 German Cancer Research Center, Proteomics of Stem Cells and Cancer, Heidelberg, Germany

Ekaterina Stepanova

4 German Cancer Research Center, Translational Control and Metabolism, Heidelberg, Germany

Michael Daskalakis

5 Inselspital, Hematology and Central Hematology Laboratory, Bern, Switzerland

Marissa Dubbelaar

2 University Hospital Tübingen, Peptide-based Immunotherapy, Tübingen, Germany

Boris Klimovich

6 Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, Tübingen, Germany

Melanie Maerklin

6 Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, Tübingen, Germany

Malte Roerden

7 University Hospital Tübingen, Department of Hematology, Oncology, Clinical Immunology and Rheumatology, Tübingen, Germany

Oliver Muecke

1 German Cancer Research Center, Cancer Epigenomics, Heidelberg, Germany

Hans-Georg Rammensee

8 Institute for Cell Biology, Department of Immunology, Tübingen, Germany

Fabricio Loayza-Puch

4 German Cancer Research Center, Translational Control and Metabolism, Heidelberg, Germany

Jeroen Krijgsveld

3 German Cancer Research Center, Proteomics of Stem Cells and Cancer, Heidelberg, Germany

Michael Lübbert

9 Faculty of Medicine and Medical Center - University of Freiburg, Department of Hematology, Oncology, and Stem-Cell Transplantation, Freiburg, Germany

Juliane Walz

2 University Hospital Tübingen, Peptide-based Immunotherapy, Tübingen, Germany

Christoph Plass

1 German Cancer Research Center, Cancer Epigenomics, Heidelberg, Germany